MicroRNAs regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets
Top Cited Papers
Open Access
- 5 October 2024
- journal article
- review article
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-11
Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression by binding to target messenger RNA (mRNA) molecules and promoting their degradation or blocking their translation. Parkinson’s disease (PD) is a neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra. There is increasing evidence to suggest that miRNAs play a role in the pathogenesis of PD. Studies have identified several miRNAs that are dysregulated in the brains of PD patients, and animal models of the disease. MiRNA expression dysregulation contributes to the onset and progression of PD by modulating neuroinflammation, oxidative stress, and protein aggregation genes. Moreover, miRNAs have emerged as potential therapeutic targets for PD. This review elucidates the changes in miRNA expression profiles associated with PD, emphasising their potential as diagnostic biomarkers and therapeutic targets, and detailing specific miRNAs implicated in PD and their downstream targets. Integrated Insights into miRNA Function, Microglial Activation, Diagnostic, and Treatment Prospects in PD Note: This figure is an original figure created by the authors.Keywords
This publication has 151 references indexed in Scilit:
- Effective inhibition of miR‐330/SHIP1/NF‐κB signaling pathway via miR‐330 sponge repolarizes microglia differentiationCell Biology International, 2020
- Non‐Motor Symptoms in Parkinson's Disease are Reduced by NabiloneAnnals of Neurology, 2020
- Down regulation of miR‐218, miR‐124, and miR‐144 relates to Parkinson's disease via activating NF‐κB signalingThe Kaohsiung Journal of Medical Sciences, 2020
- MicroRNA‐150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's diseaseMolecular Genetics & Genomic Medicine, 2020
- Characterization of Alzheimer’s Disease Micro-RNA Profile in Exosome-Enriched CSF Samples2019
- MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse modelJournal of Cellular Physiology, 2019
- Cell‐to‐cell communication: microRNAs as hormonesMolecular Oncology, 2017
- Downregulation of miR‐7116‐5p in microglia by MPP+ sensitizes TNF‐α production to induce dopaminergic neuron damageGlia, 2017
- Interplay between miRNAs and human diseasesJournal of Cellular Physiology, 2017
- Blood–brain barrier dysfunction in parkinsonian midbrain in vivoAnnals of Neurology, 2005